Why the study?
How do quantitative EEG and regional cerebral blood flow correlate with disease severity and neuropsychological function in patients with Alzheimer's disease compared to controls?
Population
31 patients in different stages of Alzheimer's disease and control subjects
Design
Cross-sectional
Authors
Loading...
qEEG slowing and temporoparietal hypoperfusion track AD severity; supports functional biomarker research but leaves open diagnostic utility.
How do quantitative EEG and regional cerebral blood flow correlate with disease severity and neuropsychological function in patients with Alzheimer's disease compared to controls?
Both regional cerebral blood flow evaluation and quantitative EEG provide functional information related to the severity of cognitive impairment in Alzheimer's disease.
Passero et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: